Recent News

• 04.14.2026 - Galera Therapeutics and Obsidian Therapeutics Announce Merger Agreement and $350 Million Concurrent Private Placement

Recent Filings

• 04.15.2026 - 425 Prospectuses and communications, business combinations
• 04.14.2026 - 425 Prospectuses and communications, business combinations
• 04.14.2026 - 8-K Current report
• 04.14.2026 - 425 Prospectuses and communications, business combinations
• 04.14.2026 - 425 Prospectuses and communications, business combinations
• 04.14.2026 - 425 Prospectuses and communications, business combinations
• 04.14.2026 - EX-99.1 EX-99.1
• 04.10.2026 - SCHEDULE 13D General Statement of Acquisition of Beneficial Ownership
• 04.10.2026 - PRE 14A Other preliminary proxy statements
• 04.09.2026 - 4 Statement of changes in beneficial ownership of securities